Home » Topics » BioWorld Science

BioWorld Science
RSS

Molsidomine reduces upregulated prostacyclin synthase mRNA in hypoxic pulmonary hypertension

Oct. 4, 2001

Human monoclonal antibody targeting IL-15 advances to clinical trials in RA patients

Oct. 4, 2001

Sch-351125: an orally bioavailable anti-HIV CCR5 antagonist

Oct. 4, 2001

Marine sponge-derived compound with antiinflammatory properties

Oct. 4, 2001

Chromax dietary supplement undergoes clinical testing for treatment of depression

Oct. 4, 2001

FDA approves Dermagraft living human dermal substitute

Oct. 4, 2001

ICN acquires promising liver-targeting hepatitis B compound

Oct. 4, 2001

AtheroGenics begins phase I trial of AGIX-4207 for rheumatoid arthritis

Oct. 4, 2001

Phase II trial to compare two ciprofloxacin formulations for urinary tract infections

Oct. 4, 2001

FDA accepts for review Picovir NDA for use in the common cold

Oct. 4, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...